NPS Pharmaceuticals Newswire

NPS Pharmaceuticals Newswire

Comprehensive Real-Time News Feed for NPS Pharmaceuticals.

Results 1 - 20 of 48 in NPS Pharmaceuticals

  1. Them on Us 6.8.16Read the original story

    Tuesday Jun 7 | Planet Jackson Hole

    Bad behavior and poor decision-making continues at the nation's first national park. Author Lee H. Whittlesey can forget adding a chapter or two to his 1995 and 2014 editions of Death in Yellowstone .

    Comment?

  2. Advanced Accelerator Applications Appoints Francois Nader, M.D., to Board of DirectorsRead the original story w/Photo

    May 26, 2016 | GlobeNewswire

    ... scientific roles. From 2008 to 2015, Dr. Nader served as the President and Chief Executive Officer of NPS Pharmaceuticals, Inc. and previously served as Chief Operating Officer in 2007, and Chief Medical and Commercial officer in 2006. During his ...

    Comment?

  3. In rare win for nature, photo project shows little change at YellowstoneRead the original story w/Photo

    May 23, 2016 | Christian Science Monitor

    A Yellowstone photographer recreated the first images ever of the region, which helped convince Congress to designate it as the world's first national park. The Grotto, shown here on August 24, 2012, was the only geyser William Henry Jackson was able to photograph in eruption during the 1871 Hayden Survey.

    Comment?

  4. Aurinia Reports First Quarter 2016 Financial Results and Operational HighlightsRead the original story w/Photo

    May 11, 2016 | Business Wire

    ... rket access, distribution and patient services. He served as Vice President, Access and Reimbursement at NPS Pharmaceuticals, until it was acquired by Shire plc. Prior to

    Comment?

  5. uniQure Appoints As Chief Commercial OfficerRead the original story

    May 2, 2016 | BioSpace

    Mr. Firuta, who held similar positions at NPS Pharmaceuticals, Inc. and ViroPharma, Inc., has 25 years of industry experience successfully commercializing products targeting rare diseases. As a key member of the leadership team, Mr. Firuta will oversee global commercial and portfolio planning, program management, and will work closely with the Company's cross-functional teams in building relationships with patient advocacy groups and key opinion leaders.

    Comment?

  6. Shire Quarterly Profit Tops Estimates as Drug Sales SoarRead the original story

    Apr 29, 2016 | The Washington Post

    Shire Plc reported first-quarter earnings that beat analysts' estimates as sales climbed for its key ADHD drug and medicines to treat rare diseases obtained in last year's acquisition of NPS Pharmaceuticals Inc. Earnings per American depositary shares rose to $3.19, the Dublin-based company said in a statement on Friday. That compared with the $3.05 average of 15 analysts' estimates compiled by Bloomberg.

    Comment?

  7. Shire Quarterly Profit Tops Estimates as Drug Sales SoarRead the original story

    Apr 29, 2016 | The Washington Post

    Shire Plc reported first-quarter earnings that beat analysts' estimates as sales climbed for its key ADHD drug and medicines to treat rare diseases obtained in last year's acquisition of NPS Pharmaceuticals Inc. Earnings per American depositary shares rose to $3.19, the Dublin-based company said in a statement on Friday. That compared with the $3.05 average of 15 analysts' estimates compiled by Bloomberg.

    Comment?

  8. Shire Delivers Strong Q1 2016 Results With Double-Digit Growth In...Read the original story

    Apr 28, 2016 | BioSpace

    ... measures prepared in accordance with US GAAP on pages 19 - 22. Rare disease products acquired from NPS Pharmaceuticals, Inc. ("NPS") continued to perform well with GATTEX/REVESTIVE sales up 247% (up 97% on a pro-forma basis(1)) to Free cash flow ...

    Comment?

  9. The call of Acadia brings organizer Jack Russell homeRead the original story w/Photo

    Feb 21, 2016 | Bangor Daily News

    Jack Russell spent a lifetime organizing people and heeding the call of public service. He didn't stop when he returned 10 years ago to live year round in the home where he was raised on Mount Desert Island.

    Comment?

  10. Buffalo Bill Center of the West Shares Discovery of Rare Albertype Photos of YellowstoneRead the original story

    Feb 18, 2016 | PRWeb

    The Buffalo Bill Center of the West announces the discovery of an extremely rare collection of Albertype photographs from the 1871 U.S. Geological Survey of Yellowstone National Park. Collector Dr. Robert Enteen has loaned the images in honor of the National Park Service's 100th Anniversary.

    Comment?

  11. The Presidents Who Gave Us Our Best ParksRead the original story

    Feb 12, 2016 | National Geographic

    Some of the greatest legacies of U.S. presidents are the parks they leave behind. Today President Obama designated three new national monuments in California: Castle Mountains National Monument, Sand to Snow National Monument, and Mojave Trails National Monument.

    Comment?

  12. Find Your Adventure: Mardi Gras SideshowRead the original story w/Photo

    Feb 10, 2016 | Motorhome

    If you're headed to New Orleans for Mardi Gras, you may be wondering how you'll fill the hours before and after the city's legendary over-the-top parades. Well, in this latest installment of our Find Your Adventure series , celebrating the 100th anniversary of the founding of the National Park Service, you'll find the NPS folks are right there to help! For starters stop by the National Park Service's Jean Lafitte Visitor Center in the French Quarter.

    Comment?

  13. Local Entrepreneurs Launch Eco-Friendly Junk Removal ServiceRead the original story w/Photo

    Feb 2, 2016 | Utah Business

    Salt Lake City-Salt Lake City households and businesses can soon revel in a royal coronation. The launch of Junk King in the City of the Saints signals a crowning moment-the beginning of junk removal services in the market that has earned nationwide acclaim for its unrivaled customer service and incomparable eco-friendly approach.

    Comment?

  14. Actinium Pharmaceuticals Announces New Hires to Product Development and Clinical Research TeamsRead the original story

    Jan 26, 2016 | Freshnews

    ... in the area of Chemistry, Manufacturing and Control (CMC). Most Recently, Ms. Choudrie worked at NPS Pharmaceuticals as Senior Director, Pharmaceutical Development, Global Technical Operations where she directed formulation development, process ...

    Comment?

  15. Shire buys Baxalta for $32bnRead the original story w/Photo

    Jul 1, 2015 | Iol.co.za

    ... rare diseases space after a planned takeover by US drugmaker AbbVie fell through last year. He bought NPS Pharmaceuticals for $5.2 billion in February and Dyax for $5.9 billion in November. According to Freeman/Thomson Reuters estimates, Shire's ...

    Comment?

  16. Shire acquiring Baxalta for $32 billionRead the original story w/Photo

    Jan 11, 2016 | Pacific Business Times

    ... including the November purchase of Dyax Inc. for $5.9 billion and the $5 billion acquisition of NPS Pharmaceuticals Inc. in February 2015. Shire has been bulking up following AbbVie Inc.'s abandoned $52 billion buyout of the company last year. The ...

    Comment?

  17. Drugmaker Shire buys Baxalta for $32 billion after six-month pursuitRead the original story

    Jan 11, 2016 | WNFL-AM Green Bay

    ... diseases space after a planned takeover by U.S. drugmaker AbbVie Inc fell through last year. He bought NPS Pharmaceuticals for $5.2 billion in February and Dyax for $5.9 billion in November. According to Freeman/Thomson Reuters estimates, Shire's ...

    Comment?

  18. Shire to combine with Baxalta in deal valued around $32 billionRead the original story w/Photo

    Jan 11, 2016 | The Day

    ... including the November purchase of Dyax Inc. for $5.9 billion and the $5 billion acquisition of NPS Pharmaceuticals Inc. in February 2015. Shire has been bulking up following AbbVie's abandoned $52 billion buyout of the company last year. The deals ...

    Comment?

  19. Shire Wins Baxalta With Revised $32 Billion Bid, Including CashRead the original story

    Jan 11, 2016 | The Washington Post

    ... including the November purchase of Dyax Inc. for $5.9 billion and the $5 billion acquisition of NPS Pharmaceuticals Inc. in February 2015. Shire has been bulking up following AbbVie Inc.'s abandoned $52 billion buyout of the company last year. The ...

    Comment?

  20. Shire Said in Advanced Talks to Acquire Drugmaker BaxaltaRead the original story

    Jan 4, 2016 | The Washington Post

    ... ns, including the November purchase of Dyax Inc. for $5.9 billion and the $5 billion acquisition of NPS Pharmaceuticals Inc. in February. The drugmaker has been bulking up following AbbVie Inc.'s abandoned $52 billion buyout of the company last year.

    Comment?